NGM Biopharmaceuticals: A Unique NASH Business Model To Watch
Seeking Alpha,
Summary NGM Biopharmaceuticals ( NGM ) is a business focused on large markets with diseases driven by clear mechanisms-of-action.
Summary NGM Biopharmaceuticals ( NGM ) is a business focused on large markets with diseases driven by clear mechanisms-of-action.
Liver doctors are noticing a change in their clinics. From Rochester, New York, to Plano, Texas, more patients are showing up…
There's one surefire way to diagnose a liver disease that, by some estimates, affects tens of millions of Americans — and it…
Summary Conatus is expected to report top line data readouts for emricasan in Phase 2b clinical trials, NASH severe Portal…